Seroprevalence of human T-cell lymphotropic virus type 1 and 2 in blood donors from the regional hospital of Valdivia, Chile

Medical Microbiology and Immunology

Volumn 199, Issue 4, 2010, Pages 341-344

  Chandía, Luis ^a,b   Sotomayor, Cristina ^a   Ordenes, Sylvia ^b   Salas, Pilar ^b   Navarrete, Maritza ^a,b   Lopez, Mauricio ^a   Otth, Carola ^a  

^a UNIVERSIDAD AUSTRAL DE CHILE   (Chile)

^b Medical School   (Chile)

Author keywords

Blood donors; Blood transfusion; HTLV

Indexed keywords

VIRUS ANTIBODY;

ADULT; ANTIBODY SCREENING; ARTICLE; BLOOD BANK; BLOOD DONOR; CHILE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS INFECTION; MALE; MANDATORY TESTING; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SEROPREVALENCE; VIRUS DETECTION;

ADULT; ANIMALS; ANTIBODIES, VIRAL; BLOOD DONORS; CHILE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HTLV-I INFECTIONS; HTLV-II INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; REAGENT KITS, DIAGNOSTIC; SEROEPIDEMIOLOGIC STUDIES; VIROLOGY;

EID: 78449311280     PISSN: 03008584     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00430-010-0166-x     Document Type: Article

References (28)

1. FA Proietti AB Carneiro-Proietti BC Catalan-Soares EL Murphy 2005 Global epidemiology of HTLV-I infection and associated diseases Oncogene 24 6058 6068 1:CAS:528:DC%2BD2MXpvFertb8%3D 10.1038/sj.onc.1208968 16155612
2. BJ Poiesz FW Ruscetti AF Gazdar PA Bunn JD Minna RC Gallo 1980 Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma Proc Natl Acad Sci USA 77 7415 7419 1:CAS:528:DyaL3MXhtlOnt74%3D 10.1073/pnas.77.12.7415 6261256
3. M Yoshida I Miyoshi Y Hinuma 1982 Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease Proc Natl Acad Sci USA 79 2031 2035 1:CAS:528:DyaL38Xhslyrurk%3D 10.1073/pnas.79.6.2031 6979048
4. M Osame K Usuku S Izumo N Ijichi H Amitani A Igata, et al. 1986 HTLV-I associated myelopathy, a new clinical entity Lancet 1 1031 1032 1:STN:280:DyaL283gt1aguw%3D%3D 10.1016/S0140-6736(86)91298-5 2871307
5. K Barmak E Harhaj C Grant T Alefantis B Wigdahl 2003 Human T cell leukemia virus ype I-induced disease: pathways to cancer and neurodegeneration Virology 308 1 12 1:CAS:528:DC%2BD3sXks1yns7k%3D 10.1016/S0042-6822(02)00091-0 12706085
6. RF Edlich JA Arnette FM Williams 2000 Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I) J Emerg Med 18 109 119 1:STN:280: DC%2BD3c7gvVCnug%3D%3D 10.1016/S0736-4679(99)00173-0 10645850
7. B Galvao-Castro L Loures LG Rodriques A Sereno OC Ferreira Jr LG Franco, et al. 1997 Distribution of human T-lymphotropic virus type I among blood donors: a nationwide Brazilian study Transfusion 37 242 243 1:STN:280: DyaK2s3gtlGgsA%3D%3D 10.1046/j.1537-2995.1997.37297203532.x 9051104
8. M Kazanji A Gessain 2003 Human T-cell lymphotropic virus types I and II (HTLV-I/II) in French Guiana: clinical and molecular epidemiology Cad Saude Pub 19 1227 1240
9. G Leon AM Quiros JL Lopez M Hung AM Diaz J Goncalves, et al. 2003 Seropositivity for human T-lymphotropic virus types I and II among donors at the municipal blood bank of caracas and associated risk factors Rev Panam Salud Pub 13 117 123
10. C Sanchez-Palacios E Gotuzzo AM Vandamme Y Maldonado 2003 Seroprevalence and risk factors for human T-cell lymphotropic virus (HTLV-I) infection among ethnically and geographically diverse peruvian women Int J Infect Dis 7 132 137 1:STN:280:DC%2BD3szhtFKltA%3D%3D 10.1016/S1201-9712(03)90009-9 12839715
11. R Gastaldello WW Hall S Gallego 2004 Seroepidemiology of HTLV-I/II in Argentina: an overview J Acq Immun Def Synd 35 301 308 10.1097/00126334- 200403010-00012
12. V Zaninovic F Sanson F Lopez G Velandia A Blank M Blank, et al. 1993 Geographic independence of HTLV-I and HTLV-II foci in the andes highland, the Atlantic coast, and the orinoco of Colombia AIDS Res Hum Retrovir 10 97 101 10.1089/aid.1994.10.97
13. L Cartier K Tajima F Araya JL Castillo V Zaninovic M Hayami, et al. 1993 Preliminary report on the prevalence of serum antibodies against HTLV-I in Chilean aboriginal populations Rev Med Chile 121 242 246
14. J Inostroza P Diaz C Saunier 1991 Prevalence of antibodies to HTLV-1 in south American Indians (Mapuches) from Chile Scand J Infect Dis 23 507 508 1:STN:280:DyaK38%2Fms12iuw%3D%3D 10.3109/00365549109075102 1957135
15. P Vasquez G Sánchez C Volante L Vera E Ramírez G Soto, et al. 1991 Human T-Lymphotropic virus type I: new risk for Chilean population Blood 78 850 851 1:STN:280:DyaK3Mzhs1ejtg%3D%3D 1859897
16. P Vasquez 2003 HTLV-I (Human T-cell lymphotropic virus), algo que decir? Rev Chil Infect 20 Supl 1 S34 S37
17. Cartier L, Cartier E (1996) HTLV-I-II in Chile. In: Zaninovic V (ed) HTLV, truths and questions. Fund. Mar, Cali, pp 150-158
18. L Cartier C Mora J Araya J Castillo R Verdugo MA Miller, et al. 1989 HTLV-I positive spastic paraparesis in a temperate zone Lancet 1 556 557
19. H Galeno E Ramirez J Mora M Ojeda L Cartier 1994 Anti HTLV-I antibody titers in seropositive infected individuals Rev Med Chile 122 1004 1007 1:STN:280:DyaK2MzitVCksA%3D%3D 7597329
20. L Cartier F Araya JL Castillo R Verdugo C Mora DC Gajdusek C Gibbs 1990 HTLV-I provirus in Chile, study of 140 neurological patients Rev Med Chile 118 622 628 1:STN:280:DyaK387jt1aktA%3D%3D 1775782
21. H Galeno E Ramirez L Cartier 1996 HTLV-I provirus in seronegative chilean patients with tropical spastic paraparesis Lancet 348 1170 1:STN:280: DyaK2s%2Fkt12qsA%3D%3D 10.1016/S0140-6736(05)65303-2 8888190
22. E Ramirez L Cartier R Flores 2004 In vitro cytoskeleton changes of mouse neurons induced by purified HTLV-I, and PBMC from HAM/TSP patients and HTLV-I carriers Arch Virol 149 2307 2317 1:CAS:528:DC%2BD2cXhtVWjt7bO 10.1007/s00705-004-0387-7 15338322
23. E Ramirez L Cartier M Torres M Barria 2007 Temporal dynamics of human T-lymphotropic virus type I tax mRNA and proviral DNA load in peripheral blood mononuclear cells of human T-lymphotropic virus type I-associated myelopathy patients J Med Virol 79 782 790 1:CAS:528:DC%2BD2sXlvFChtr4%3D 10.1002/jmv.20844 17457906
24. HC Li T Fujiyoshi H Lou S Yashiki S Sonoda L Cartier, et al. 1999 The presence of ancient human T-cell lymphotropic virus type I provirus DNA in an andean mummy Nat Med 5 1428 1432 1:CAS:528:DyaK1MXnvFGgtbs%3D 10.1038/15256 10581088
25. L Cartier F Araya JL Castillo V Zaninovic M Hayami T Miura, et al. 1993 Southern-most carriers of HTLV-I/II in the world Jpn J Cancer Res 84 1 3 1:STN:280:DyaK3s7psVKrsw%3D%3D 8449820
26. T Uchiyama 1997 Human T cell leukemia virus type I (HTLV-I) and human diseases Annu Rev Immunol 15 15 37 1:CAS:528:DyaK2sXisVCnsLs%3D 10.1146/annurev.immunol.15.1.15 9143680
27. A Manns RJ Wilks EL Murphy G Haynes JP Figueroa M Barnett, et al. 1992 A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion Int J Cancer 51 886 891 1:STN:280: DyaK38zkvVSmsQ%3D%3D 10.1002/ijc.2910510609 1639536
28. CA Berini M Susana Pascuccio CT Bautista SA Gendler ME Eirin C Rodriguez MA Pando MM Biglione 2008 Comparison of four commercial screening assays for the diagnosis of human T-cell lymphotropic virus types 1 and 2 J Virol Methods 147 322 327 1:CAS:528:DC%2BD1cXisFKmsA%3D%3D 10.1016/j.jviromet.2007.09.012 17977605